These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30591320)

  • 1. Comparison of heart rate reduction effect and safety between bisoprolol transdermal patch and bisoprolol fumarate oral formulation in Japanese patients with persistent/permanent atrial fibrillation (BISONO-AF study).
    Yamashita T; Ikeda T; Akita Y
    J Cardiol; 2019 May; 73(5):386-393. PubMed ID: 30591320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of efficacy and safety between bisoprolol transdermal patch (TY-0201) and bisoprolol fumarate oral formulation in Japanese patients with grade I or II essential hypertension: randomized, double-blind, placebo-controlled study.
    Matsuoka H; Kuwajima I; Shimada K; Mitamura H; Saruta T
    J Clin Hypertens (Greenwich); 2013 Nov; 15(11):806-14. PubMed ID: 24119112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heart rate-reducing effects of bisoprolol in Japanese patients with chronic atrial fibrillation: results of the MAIN-AF study.
    Yamashita T; Inoue H
    J Cardiol; 2013 Jul; 62(1):50-7. PubMed ID: 23611172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Safety of Switching From Oral Bisoprolol to Transdermal Patch in Japanese Patients With Chronic Heart Failure.
    Momomura SI; Saito Y; Yasumura Y; Yamamoto K; Sakata Y; Daimon M; Kinugawa K; Okamoto H; Dohi N; Komuro I
    Circ J; 2017 Dec; 82(1):141-147. PubMed ID: 28768917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An attempt at administering a transdermal formulation of bisoprolol in patients with acute cardiac symptoms.
    Nozaki A; Kobayashi T; Naruhashi K; Okugawa H; Horiuchi N; Nakanishi H; Kobayashi Y; Nakamura S
    Am J Emerg Med; 2021 Jan; 39():146-150. PubMed ID: 33039223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of a novel transdermal selective β1-blocker, the bisoprolol patch, for treating frequent premature ventricular contractions in patients without structural heart disease.
    Shinohara M; Fujino T; Koike H; Kitahara K; Kinoshita T; Yuzawa H; Suzuki T; Fukunaga S; Kobayashi K; Aoki J; Tanabe K; Ikeda T
    J Cardiol; 2017 Sep; 70(3):212-219. PubMed ID: 28343798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart rate control by carvedilol in Japanese patients with chronic atrial fibrillation: The AF Carvedilol study.
    Inoue H; Atarashi H; Okumura K; Yamashita T; Fukuzawa M; Shiosakai K; Kimura T
    J Cardiol; 2017 Jan; 69(1):293-301. PubMed ID: 27364549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Digoxin vs Bisoprolol for Heart Rate Control in Atrial Fibrillation on Patient-Reported Quality of Life: The RATE-AF Randomized Clinical Trial.
    Kotecha D; Bunting KV; Gill SK; Mehta S; Stanbury M; Jones JC; Haynes S; Calvert MJ; Deeks JJ; Steeds RP; Strauss VY; Rahimi K; Camm AJ; Griffith M; Lip GYH; Townend JN; Kirchhof P;
    JAMA; 2020 Dec; 324(24):2497-2508. PubMed ID: 33351042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Head-to-head comparison of the heart rate variability between the bisoprolol transdermal patch and bisoprolol fumarate tablet.
    Sairaku A; Nakano Y; Shiode N; Suenari K; Oda N; Ono K; Kihara Y
    Cardiovasc Ther; 2018 Jun; 36(3):e12325. PubMed ID: 29464917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managing postoperative atrial fibrillation after open-heart surgery using transdermal β
    Yamamoto K; Miwa S; Yamada T; Setozaki S; Hamuro M; Kurokawa S; Enomoto S
    J Cardiothorac Surg; 2023 Apr; 18(1):103. PubMed ID: 37024987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Switching therapy from intravenous beta blocker to bisoprolol transdermal patch for atrial fibrillation tachycardia.
    Nakamura K; Inokuchi R; Hiruma T; Tokunaga K; Doi K; Nakajima S
    J Anesth; 2016 Oct; 30(5):891-4. PubMed ID: 27262288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilot study of bisoprolol 8mg transdermal patch at bedtime before coronary computed tomography angiography.
    Yamazaki D; Shimura Y; Enjoji Y; Nishinaga M; Kanmatuse K; Endo M
    J Cardiol; 2020 Apr; 75(4):394-399. PubMed ID: 31627998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisoprolol transdermal patch for perioperative care of non-cardiac surgery in patients with hypertrophic obstructive cardiomyopathy.
    Imori Y; Takano H; Mase H; Matsuda J; Sangen H; Izumi Y; Tokita Y; Yamamoto T; Shimizu W
    BMC Cardiovasc Disord; 2019 Dec; 19(1):316. PubMed ID: 31888491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial Fibrillation After Coronary Artery Bypass Surgery: Can Ivabradine Reduce Its Occurrence?
    Abdel-Salam Z; Nammas W
    J Cardiovasc Electrophysiol; 2016 Jun; 27(6):670-6. PubMed ID: 27006322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of postoperative atrial fibrillation in transdermal β-blocker patch users is lower than that in oral β-blocker users after cardiac and/or thoracic aortic surgery.
    Okamura H; Arakawa M; Miyagawa A; Adachi H
    Gen Thorac Cardiovasc Surg; 2019 Dec; 67(12):1007-1013. PubMed ID: 31049816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of rate control in atrial fibrillation, and the rationale and protocol for the RATE-AF trial.
    Kotecha D; Calvert M; Deeks JJ; Griffith M; Kirchhof P; Lip GY; Mehta S; Slinn G; Stanbury M; Steeds RP; Townend JN
    BMJ Open; 2017 Jul; 7(7):e015099. PubMed ID: 28729311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supraventricular tachyarrhythmias that responded dramatically to bisoprolol transdermal patches in two patients undergoing hemodialysis.
    Matsumoto T; Tamiya E; Yamamoto S; Kamiyama T; Takabe T; Kanoh T; Daida H
    Ann Noninvasive Electrocardiol; 2019 Nov; 24(6):e12660. PubMed ID: 31190422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Bisoprolol Transdermal Patches for Prevention of Perioperative Myocardial Injury in High-Risk Patients Undergoing Non-Cardiac Surgery　- Multicenter Randomized Controlled Study.
    Toda H; Nakamura K; Shimizu K; Ejiri K; Iwano T; Miyoshi T; Nakagawa K; Yoshida M; Watanabe A; Nishii N; Hikasa Y; Hayashi M; Morita H; Morimatsu H; Ito H;
    Circ J; 2020 Mar; 84(4):642-649. PubMed ID: 32092717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the Transdermal Bisoprolol Patch with Oral Bisoprolol Fumarate Administration as a Therapeutic Agent for Idiopathic Frequent Premature Ventricular Contractions.
    Shinohara M; Wada R; Yao S; Yano K; Akitsu K; Koike H; Kinoshita T; Yuzawa H; Suzuki T; Fujino T; Ikeda T
    Int Heart J; 2020 May; 61(3):510-516. PubMed ID: 32418969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart rate and outcome in heart failure with reduced ejection fraction: Differences between atrial fibrillation and sinus rhythm-A CIBIS II analysis.
    Mulder BA; Damman K; Van Veldhuisen DJ; Van Gelder IC; Rienstra M
    Clin Cardiol; 2017 Sep; 40(9):740-745. PubMed ID: 28513877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.